KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Debt Ratio (2018 - 2025)

Historic Debt Ratio for Castle Biosciences (CSTL) over the last 6 years, with Q3 2025 value amounting to 0.02.

  • Castle Biosciences' Debt Ratio fell 825.79% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 825.79%. This contributed to the annual value of 0.02 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Castle Biosciences' Debt Ratio is 0.02, which was down 825.79% from 0.02 recorded in Q2 2025.
  • Castle Biosciences' 5-year Debt Ratio high stood at 0.05 for Q1 2022, and its period low was 0.02 during Q3 2025.
  • Over the past 3 years, Castle Biosciences' median Debt Ratio value was 0.02 (recorded in 2024), while the average stood at 0.02.
  • Data for Castle Biosciences' Debt Ratio shows a peak YoY increase of 825.79% (in 2025) and a maximum YoY decrease of 1025.44% (in 2025) over the last 5 years.
  • Quarter analysis of 3 years shows Castle Biosciences' Debt Ratio stood at 0.05 in 2022, then plummeted by 59.78% to 0.02 in 2024, then dropped by 5.36% to 0.02 in 2025.
  • Its Debt Ratio was 0.02 in Q3 2025, compared to 0.02 in Q2 2025 and 0.02 in Q1 2025.